0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Rabies Vaccine Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-12F9112
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Rabies Vaccine Market Outlook 2022
BUY CHAPTERS

Global Human Rabies Vaccine Market Research Report 2026

Code: QYRE-Auto-12F9112
Report
2026-04-10
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Rabies Vaccine Market Size

The global Human Rabies Vaccine market was valued at US$ 1192 million in 2025 and is anticipated to reach US$ 1595 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Human Rabies Vaccine Market

Human Rabies Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Rabies Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
The increasing awareness of rabies prevention and the rising number of reported cases of animal bites, particularly in developing countries, are key drivers of the human rabies vaccine market. Government-led vaccination programs, international health initiatives, and educational campaigns have significantly boosted demand for pre- and post-exposure prophylaxis, including human rabies vaccines. Moreover, improvements in vaccine technology, such as the development of safer and more effective vaccines, are also contributing to the growth of the market.
One major challenge in the human rabies vaccine market is the uneven access to vaccines, especially in regions where rabies is endemic. High costs, cold chain requirements for storage, and distribution challenges in rural or underdeveloped areas make it difficult for healthcare providers to ensure timely vaccination. Additionally, a lack of healthcare infrastructure and trained personnel to administer the vaccine can hinder its effectiveness in regions most affected by rabies, limiting the overall impact of vaccination efforts.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share. Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
This report delivers a comprehensive overview of the global Human Rabies Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Rabies Vaccine. The Human Rabies Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Rabies Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Rabies Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Human Rabies Vaccine Market Report

Report Metric Details
Report Name Human Rabies Vaccine Market
Accounted market size in 2025 US$ 1192 in million
Forecasted market size in 2032 US$ 1595 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Vero Cell
  • BHK
  • Chick Embryo Cell
  • Human Diploid Cells
  • Others
by Application
  • Pre-Exposure Vaccine
  • Post-Exposure Vaccine
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Human Rabies Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Human Rabies Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Human Rabies Vaccine Market growing?

Ans: The Human Rabies Vaccine Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Human Rabies Vaccine Market size in 2032?

Ans: The Human Rabies Vaccine Market size in 2032 will be US$ 1595 million.

What is the Human Rabies Vaccine Market share by region?

Ans: Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

Who are the main players in the Human Rabies Vaccine Market report?

Ans: The main players in the Human Rabies Vaccine Market are Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals

What are the Application segmentation covered in the Human Rabies Vaccine Market report?

Ans: The Applications covered in the Human Rabies Vaccine Market report are Pre-Exposure Vaccine, Post-Exposure Vaccine

What are the Type segmentation covered in the Human Rabies Vaccine Market report?

Ans: The Types covered in the Human Rabies Vaccine Market report are Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, Others

1 Human Rabies Vaccine Market Overview
1.1 Product Definition
1.2 Human Rabies Vaccine by Type
1.2.1 Global Human Rabies Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Human Rabies Vaccine by Application
1.3.1 Global Human Rabies Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Pre-Exposure Vaccine
1.3.3 Post-Exposure Vaccine
1.4 Global Human Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Vaccine Revenue 2021–2032
1.4.2 Global Human Rabies Vaccine Sales 2021–2032
1.4.3 Global Human Rabies Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Rabies Vaccine Market Competition by Manufacturers
2.1 Global Human Rabies Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Rabies Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Rabies Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Rabies Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Rabies Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Human Rabies Vaccine, Date of Entry into the Industry
2.8 Global Human Rabies Vaccine Market Competitive Situation and Trends
2.8.1 Global Human Rabies Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Rabies Vaccine Players Market Share by Revenue
2.8.3 Global Human Rabies Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Rabies Vaccine Market Scenario by Region
3.1 Global Human Rabies Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Rabies Vaccine Sales by Region: 2021–2032
3.2.1 Global Human Rabies Vaccine Sales by Region: 2021–2026
3.2.2 Global Human Rabies Vaccine Sales by Region: 2027–2032
3.3 Global Human Rabies Vaccine Revenue by Region: 2021–2032
3.3.1 Global Human Rabies Vaccine Revenue by Region: 2021–2026
3.3.2 Global Human Rabies Vaccine Revenue by Region: 2027–2032
3.4 North America Human Rabies Vaccine Market Facts & Figures by Country
3.4.1 North America Human Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Rabies Vaccine Sales by Country (2021–2032)
3.4.3 North America Human Rabies Vaccine Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Rabies Vaccine Market Facts & Figures by Country
3.5.1 Europe Human Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Rabies Vaccine Sales by Country (2021–2032)
3.5.3 Europe Human Rabies Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Human Rabies Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Rabies Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Rabies Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Rabies Vaccine Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Rabies Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Human Rabies Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Rabies Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Rabies Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Rabies Vaccine Sales by Type (2021–2032)
4.1.1 Global Human Rabies Vaccine Sales by Type (2021–2026)
4.1.2 Global Human Rabies Vaccine Sales by Type (2027–2032)
4.1.3 Global Human Rabies Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Human Rabies Vaccine Revenue by Type (2021–2032)
4.2.1 Global Human Rabies Vaccine Revenue by Type (2021–2026)
4.2.2 Global Human Rabies Vaccine Revenue by Type (2027–2032)
4.2.3 Global Human Rabies Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Human Rabies Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Rabies Vaccine Sales by Application (2021–2032)
5.1.1 Global Human Rabies Vaccine Sales by Application (2021–2026)
5.1.2 Global Human Rabies Vaccine Sales by Application (2027–2032)
5.1.3 Global Human Rabies Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Human Rabies Vaccine Revenue by Application (2021–2032)
5.2.1 Global Human Rabies Vaccine Revenue by Application (2021–2026)
5.2.2 Global Human Rabies Vaccine Revenue by Application (2027–2032)
5.2.3 Global Human Rabies Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Human Rabies Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Company Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bharat Biotech Human Rabies Vaccine Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Bavarian Nordic
6.2.1 Bavarian Nordic Company Information
6.2.2 Bavarian Nordic Description and Business Overview
6.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bavarian Nordic Human Rabies Vaccine Product Portfolio
6.2.5 Bavarian Nordic Recent Developments/Updates
6.3 Sanofi-Pasteur
6.3.1 Sanofi-Pasteur Company Information
6.3.2 Sanofi-Pasteur Description and Business Overview
6.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi-Pasteur Human Rabies Vaccine Product Portfolio
6.3.5 Sanofi-Pasteur Recent Developments/Updates
6.4 Chengda Bio
6.4.1 Chengda Bio Company Information
6.4.2 Chengda Bio Description and Business Overview
6.4.3 Chengda Bio Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chengda Bio Human Rabies Vaccine Product Portfolio
6.4.5 Chengda Bio Recent Developments/Updates
6.5 KANGH
6.5.1 KANGH Company Information
6.5.2 KANGH Description and Business Overview
6.5.3 KANGH Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 KANGH Human Rabies Vaccine Product Portfolio
6.5.5 KANGH Recent Developments/Updates
6.6 Prcmise
6.6.1 Prcmise Company Information
6.6.2 Prcmise Description and Business Overview
6.6.3 Prcmise Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Prcmise Human Rabies Vaccine Product Portfolio
6.6.5 Prcmise Recent Developments/Updates
6.7 Henan Grand Biopharma
6.7.1 Henan Grand Biopharma Company Information
6.7.2 Henan Grand Biopharma Description and Business Overview
6.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Henan Grand Biopharma Human Rabies Vaccine Product Portfolio
6.7.5 Henan Grand Biopharma Recent Developments/Updates
6.8 Zhuoyi Biological
6.8.1 Zhuoyi Biological Company Information
6.8.2 Zhuoyi Biological Description and Business Overview
6.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Zhuoyi Biological Human Rabies Vaccine Product Portfolio
6.8.5 Zhuoyi Biological Recent Developments/Updates
6.9 ZhongKe Biopharm
6.9.1 ZhongKe Biopharm Company Information
6.9.2 ZhongKe Biopharm Description and Business Overview
6.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ZhongKe Biopharm Human Rabies Vaccine Product Portfolio
6.9.5 ZhongKe Biopharm Recent Developments/Updates
6.10 Ningbo Rongan Biological
6.10.1 Ningbo Rongan Biological Company Information
6.10.2 Ningbo Rongan Biological Description and Business Overview
6.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio
6.10.5 Ningbo Rongan Biological Recent Developments/Updates
6.11 Indian Immunologicals
6.11.1 Indian Immunologicals Company Information
6.11.2 Indian Immunologicals Description and Business Overview
6.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Indian Immunologicals Human Rabies Vaccine Product Portfolio
6.11.5 Indian Immunologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Vaccine Industry Chain Analysis
7.2 Human Rabies Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Vaccine Production Mode & Process Analysis
7.4 Human Rabies Vaccine Sales and Marketing
7.4.1 Human Rabies Vaccine Sales Channels
7.4.2 Human Rabies Vaccine Distributors
7.5 Human Rabies Vaccine Customer Analysis
8 Human Rabies Vaccine Market Dynamics
8.1 Human Rabies Vaccine Industry Trends
8.2 Human Rabies Vaccine Market Drivers
8.3 Human Rabies Vaccine Market Challenges
8.4 Human Rabies Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Rabies Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Human Rabies Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Human Rabies Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Human Rabies Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Human Rabies Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Human Rabies Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Human Rabies Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Human Rabies Vaccine Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Human Rabies Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Human Rabies Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Human Rabies Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Rabies Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Rabies Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Human Rabies Vaccine Sales by Region (K Units), 2021–2026
 Table 18. Global Human Rabies Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Human Rabies Vaccine Sales by Region (K Units), 2027–2032
 Table 20. Global Human Rabies Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Human Rabies Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Human Rabies Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Human Rabies Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Human Rabies Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Human Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Human Rabies Vaccine Sales by Country (K Units), 2021–2026
 Table 27. North America Human Rabies Vaccine Sales by Country (K Units), 2027–2032
 Table 28. North America Human Rabies Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Human Rabies Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Human Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Human Rabies Vaccine Sales by Country (K Units), 2021–2026
 Table 32. Europe Human Rabies Vaccine Sales by Country (K Units), 2027–2032
 Table 33. Europe Human Rabies Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Human Rabies Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Human Rabies Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Human Rabies Vaccine Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Human Rabies Vaccine Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Human Rabies Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Human Rabies Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Human Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Human Rabies Vaccine Sales by Country (K Units), 2021–2026
 Table 42. Latin America Human Rabies Vaccine Sales by Country (K Units), 2027–2032
 Table 43. Latin America Human Rabies Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Human Rabies Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Human Rabies Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Human Rabies Vaccine Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Human Rabies Vaccine Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Human Rabies Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Human Rabies Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Human Rabies Vaccine Sales (K Units) by Type (2021–2026)
 Table 51. Global Human Rabies Vaccine Sales (K Units) by Type (2027–2032)
 Table 52. Global Human Rabies Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Human Rabies Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Human Rabies Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Human Rabies Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Human Rabies Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Human Rabies Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Human Rabies Vaccine Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Human Rabies Vaccine Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Human Rabies Vaccine Sales (K Units) by Application (2021–2026)
 Table 61. Global Human Rabies Vaccine Sales (K Units) by Application (2027–2032)
 Table 62. Global Human Rabies Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Human Rabies Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Human Rabies Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Human Rabies Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Human Rabies Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Human Rabies Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Human Rabies Vaccine Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Human Rabies Vaccine Price (US$/Unit) by Application (2027–2032)
 Table 70. Bharat Biotech Company Information
 Table 71. Bharat Biotech Description and Business Overview
 Table 72. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Bharat Biotech Human Rabies Vaccine Product
 Table 74. Bharat Biotech Recent Developments/Updates
 Table 75. Bavarian Nordic Company Information
 Table 76. Bavarian Nordic Description and Business Overview
 Table 77. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Bavarian Nordic Human Rabies Vaccine Product
 Table 79. Bavarian Nordic Recent Developments/Updates
 Table 80. Sanofi-Pasteur Company Information
 Table 81. Sanofi-Pasteur Description and Business Overview
 Table 82. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Sanofi-Pasteur Human Rabies Vaccine Product
 Table 84. Sanofi-Pasteur Recent Developments/Updates
 Table 85. Chengda Bio Company Information
 Table 86. Chengda Bio Description and Business Overview
 Table 87. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Chengda Bio Human Rabies Vaccine Product
 Table 89. Chengda Bio Recent Developments/Updates
 Table 90. KANGH Company Information
 Table 91. KANGH Description and Business Overview
 Table 92. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. KANGH Human Rabies Vaccine Product
 Table 94. KANGH Recent Developments/Updates
 Table 95. Prcmise Company Information
 Table 96. Prcmise Description and Business Overview
 Table 97. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Prcmise Human Rabies Vaccine Product
 Table 99. Prcmise Recent Developments/Updates
 Table 100. Henan Grand Biopharma Company Information
 Table 101. Henan Grand Biopharma Description and Business Overview
 Table 102. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Henan Grand Biopharma Human Rabies Vaccine Product
 Table 104. Henan Grand Biopharma Recent Developments/Updates
 Table 105. Zhuoyi Biological Company Information
 Table 106. Zhuoyi Biological Description and Business Overview
 Table 107. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Zhuoyi Biological Human Rabies Vaccine Product
 Table 109. Zhuoyi Biological Recent Developments/Updates
 Table 110. ZhongKe Biopharm Company Information
 Table 111. ZhongKe Biopharm Description and Business Overview
 Table 112. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. ZhongKe Biopharm Human Rabies Vaccine Product
 Table 114. ZhongKe Biopharm Recent Developments/Updates
 Table 115. Ningbo Rongan Biological Company Information
 Table 116. Ningbo Rongan Biological Description and Business Overview
 Table 117. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Ningbo Rongan Biological Human Rabies Vaccine Product
 Table 119. Ningbo Rongan Biological Recent Developments/Updates
 Table 120. Indian Immunologicals Company Information
 Table 121. Indian Immunologicals Description and Business Overview
 Table 122. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Indian Immunologicals Human Rabies Vaccine Product
 Table 124. Indian Immunologicals Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Human Rabies Vaccine Distributors List
 Table 128. Human Rabies Vaccine Customers List
 Table 129. Human Rabies Vaccine Market Trends
 Table 130. Human Rabies Vaccine Market Drivers
 Table 131. Human Rabies Vaccine Market Challenges
 Table 132. Human Rabies Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Rabies Vaccine
 Figure 2. Global Human Rabies Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Human Rabies Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Vero Cell Product Picture
 Figure 5. BHK Product Picture
 Figure 6. Chick Embryo Cell Product Picture
 Figure 7. Human Diploid Cells Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Human Rabies Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Human Rabies Vaccine Market Share by Application: 2025 & 2032
 Figure 11. Pre-Exposure Vaccine
 Figure 12. Post-Exposure Vaccine
 Figure 13. Global Human Rabies Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Human Rabies Vaccine Market Size (US$ Million), 2021–2032
 Figure 15. Global Human Rabies Vaccine Sales (K Units), 2021–2032
 Figure 16. Global Human Rabies Vaccine Average Price (US$/Unit), 2021–2032
 Figure 17. Human Rabies Vaccine Report Years Considered
 Figure 18. Human Rabies Vaccine Sales Share by Manufacturers in 2025
 Figure 19. Global Human Rabies Vaccine Revenue Share by Manufacturers in 2025
 Figure 20. Top 5 and Top 10 Global Human Rabies Vaccine Players: Market Share by Revenue in Human Rabies Vaccine in 2025
 Figure 21. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 22. Global Human Rabies Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 23. North America Human Rabies Vaccine Sales Market Share by Country (2021–2032)
 Figure 24. North America Human Rabies Vaccine Revenue Market Share by Country (2021–2032)
 Figure 25. United States Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Canada Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Europe Human Rabies Vaccine Sales Market Share by Country (2021–2032)
 Figure 28. Europe Human Rabies Vaccine Revenue Market Share by Country (2021–2032)
 Figure 29. Germany Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. France Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. U.K. Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Italy Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Russia Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Asia Pacific Human Rabies Vaccine Sales Market Share by Region (2021–2032)
 Figure 35. Asia Pacific Human Rabies Vaccine Revenue Market Share by Region (2021–2032)
 Figure 36. China Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Japan Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. South Korea Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. India Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Australia Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. China Taiwan Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Indonesia Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Thailand Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Malaysia Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Human Rabies Vaccine Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Human Rabies Vaccine Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Human Rabies Vaccine Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Human Rabies Vaccine Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Human Rabies Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Human Rabies Vaccine by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Human Rabies Vaccine by Type (2021–2032)
 Figure 57. Global Human Rabies Vaccine Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Human Rabies Vaccine by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Human Rabies Vaccine by Application (2021–2032)
 Figure 60. Global Human Rabies Vaccine Price (US$/Unit) by Application (2021–2032)
 Figure 61. Human Rabies Vaccine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network